does glp 1 increase risk of cancer Use Glucagon-Like Peptide-1 Receptor Agonists Not the of in Patients with Type 2 Diabetes Mellitus Does GLP-1 Increase Risk of

Get the details at ADW Diabetes.

Study finds that individuals who took GLP-1 agonists for a long duration had a lower risk of going on to develop more severe forms of liver disease, including cirrhosis and liver cancer.

While peptide drugs have a wide range of therapeutic applications, their relatively short half-life has been a challenge, attributed to poor metabolic stability and a fluid dynamic radius below the glomerular filtration limit of the kidneys.

Read the full article covered by Nutritional Outlook here:

AI takes center stage at HIMSS conference gets underway in Vegas.

People working to reduce alcohol harm may feel like celebrating, but we should be wary []